Boehringer Ingelheim News Releases
See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.
News Archive
30.10.2008
Closing in on the cause of diabetes
Diabetes researcher Markus Stoffel is awarded the prestigous Heinrich Wieland Prize – Nepomuk Zöllner receives the Heinrich Wieland Medal for his lifetime achievement in gout research 24.10.2008 European CHMP adopts negative opinion on Cymbalta for the treatment of fibromyalgia For medical media, outside the US only 23.10.2008 Telmisartan (Micardis®) as effective as ramipril but with better long-term tolerability in high-risk cardiovascular Asian patients For medical media, outside the US only 22.10.2008 From Curiosity to Discovery:
Boehringer Ingelheim broadens oncology pipeline with promising new data for potentially first in class Plk1 inhibitor For medical media, outside the US only 17.10.2008 From Curiosity to Discovery:
Boehringer Ingelheim`s pipeline update unveils novel investigational compounds heralding the Company`s entry into Type 2 Diabetes
06.10.2008 ERS COPD Research Award 2008 sponsored by Boehringer Ingelheim 05.10.2008 COPD landmark trial UPLIFT® proves tiotropium sustains lung function improvements over four years and improves survival rate For medical media, outside the US only 02.10.2008 Boehringer Ingelheim signs a license agreement with Evec Inc. for its fully-human antibody programme 25.09.2008 Recent research shows significant benefits in acute ischaemic stroke with Actilyse® beyond currently approved three hour treatment window For medical media, outside the US only 24.09.2008 Positive UK health technology appraisal for novel oral anticoagulant Pradaxa® (dabigatran etexilate) For medical media, outside the US only
Diabetes researcher Markus Stoffel is awarded the prestigous Heinrich Wieland Prize – Nepomuk Zöllner receives the Heinrich Wieland Medal for his lifetime achievement in gout research 24.10.2008 European CHMP adopts negative opinion on Cymbalta for the treatment of fibromyalgia For medical media, outside the US only 23.10.2008 Telmisartan (Micardis®) as effective as ramipril but with better long-term tolerability in high-risk cardiovascular Asian patients For medical media, outside the US only 22.10.2008 From Curiosity to Discovery:
Boehringer Ingelheim broadens oncology pipeline with promising new data for potentially first in class Plk1 inhibitor For medical media, outside the US only 17.10.2008 From Curiosity to Discovery:
Boehringer Ingelheim`s pipeline update unveils novel investigational compounds heralding the Company`s entry into Type 2 Diabetes
06.10.2008 ERS COPD Research Award 2008 sponsored by Boehringer Ingelheim 05.10.2008 COPD landmark trial UPLIFT® proves tiotropium sustains lung function improvements over four years and improves survival rate For medical media, outside the US only 02.10.2008 Boehringer Ingelheim signs a license agreement with Evec Inc. for its fully-human antibody programme 25.09.2008 Recent research shows significant benefits in acute ischaemic stroke with Actilyse® beyond currently approved three hour treatment window For medical media, outside the US only 24.09.2008 Positive UK health technology appraisal for novel oral anticoagulant Pradaxa® (dabigatran etexilate) For medical media, outside the US only
